Financials
- Market Capitalization 258.85 M
- Employee 75
- Founded 2007
- CEO N/A
- Website www.cartesiantherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG001J19Q25
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.44
Relación precio/flujo de caja
66.95
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3462 | TRDA Entrada Therapeutics, Inc. - Common Stock | 6.56 USD | -0.61% | -12.18% | -0.46% | -5.88% | 254.66 M USD | ||
| 3467 | AGEN Agenus Inc. - Common Stock | 6.18 USD | +0.98% | +82.84% | +83.93% | -9.91% | 257.35 M USD | ||
| 3479 | ACIU AC Immune SA - Common Stock | 2.49 USD | +1.63% | -1.19% | +7.79% | +16.90% | 253.34 M USD | ||
| 3518 | FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.57 USD | +0.85% | -6.05% | -0.56% | -54.92% | 237.88 M USD |